State Street Corp Purchases 10,430 Shares of STAAR Surgical (NASDAQ:STAA)

State Street Corp increased its position in STAAR Surgical (NASDAQ:STAA) by 0.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,940,567 shares of the medical instruments supplier’s stock after acquiring an additional 10,430 shares during the quarter. State Street Corp owned about 3.94% of STAAR Surgical worth $72,092,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. SG Americas Securities LLC lifted its position in shares of STAAR Surgical by 173.5% during the 2nd quarter. SG Americas Securities LLC now owns 9,038 shares of the medical instruments supplier’s stock worth $430,000 after purchasing an additional 5,733 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of STAAR Surgical by 3.8% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 11,343 shares of the medical instruments supplier’s stock worth $540,000 after buying an additional 418 shares during the last quarter. Louisiana State Employees Retirement System boosted its position in shares of STAAR Surgical by 2.1% in the second quarter. Louisiana State Employees Retirement System now owns 24,700 shares of the medical instruments supplier’s stock valued at $1,176,000 after acquiring an additional 500 shares during the period. Slow Capital Inc. grew its stake in shares of STAAR Surgical by 3.1% in the second quarter. Slow Capital Inc. now owns 67,649 shares of the medical instruments supplier’s stock worth $3,221,000 after acquiring an additional 2,003 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its stake in shares of STAAR Surgical by 1.4% in the second quarter. Bank of New York Mellon Corp now owns 405,222 shares of the medical instruments supplier’s stock worth $19,293,000 after acquiring an additional 5,712 shares during the last quarter. Institutional investors and hedge funds own 96.70% of the company’s stock.

STAAR Surgical Stock Up 6.3 %

Shares of STAA opened at $25.44 on Wednesday. The company has a 50-day moving average price of $28.58 and a two-hundred day moving average price of $34.70. The stock has a market cap of $1.25 billion, a price-to-earnings ratio of 57.82 and a beta of 0.59. STAAR Surgical has a 12 month low of $23.72 and a 12 month high of $52.68.

Analyst Ratings Changes

STAA has been the subject of a number of research reports. Stifel Nicolaus reduced their price target on shares of STAAR Surgical from $50.00 to $44.00 and set a “buy” rating for the company in a report on Monday, August 26th. Canaccord Genuity Group cut their price objective on shares of STAAR Surgical from $31.00 to $28.00 and set a “hold” rating for the company in a research report on Monday, December 9th. Stephens raised STAAR Surgical to a “hold” rating in a research report on Monday, December 2nd. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of STAAR Surgical in a report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, four have given a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, STAAR Surgical has an average rating of “Hold” and an average target price of $42.83.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.